Page 35 - MI-2-1
P. 35

Microbes & Immunity





                                        REVIEW ARTICLE
                                        iPSC-mediated genetic manipulation

                                        promotes natural killer cell-centered cancer
                                        immunotherapy



                                                                1†
                                                                              2
                                                                                                3
                                                  1†
                                        Yiran Zheng , Yumo Zhang , Zhouxin Yang *, Wing Keung Chan , and
                                                   1
                                        Youwei Wang *
                                        1 Institute of Medical Engineering and Translational Medicine, Medical College, Tianjin University,
                                        Tianjin, China
                                        2 Zhejiang Provincial Key Lab of Geriatrics and Geriatrics Institute of Zhejiang Province, Zhejiang
                                        Hospital, Hangzhou, China
                                        3 Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus,
                                        Ohio, United States of America



                                        Abstract
                                        Natural killer (NK) cells demonstrate potent cytotoxic activities and the capacity to
                                        secrete cytokines. Their distinctive capability to trigger cell death, bypassing the need
            † These authors contributed equally   for major histocompatibility complex recognition, opens promising avenues for their
            to this work.               use in clinical settings such as allogeneic transplantation and tumor immunotherapy.
            *Corresponding authors:     Although the ability of NK cells to kill hematological tumors has been widely
            Zhouxin Yang                recognized, their effectiveness in treating solid tumors is not as pronounced. The
            (yangzhouxin@hotmail.com);
            Youwei Wang                 intricate interplay of NK cells with the tumor microenvironment, specifically in the
            (youwei.wang@tju.edu.cn)    context of solid malignancies, has been noted to attenuate the anti-cancer prowess
                                        of NK cells and foster the ability of malignant cells to elude immune surveillance.
            Citation: Zheng Y, Zhang Y,
            Yang  Z, Chan WK, Wang Y. iPSC-  Successful  NK  cell-centered  immunotherapy  hinges  on  obtaining  a substantial
            mediated genetic manipulation   quantity of NK cells with potent tumor-killing capabilities. However, the current
            promotes natural killer cell-centered   challenge lies in the limited ex vivo expansion of NK cells and the inefficiency of gene
            cancer immunotherapy. Microbes &
            Immunity. 2025;2(1):27-44.   introduction methods. Induced pluripotent stem cells (iPSCs) are multipotent stem
            doi: 10.36922/mi.5653       cells with relatively easier gene transfection capability and theoretically unlimited
            Received: October 28, 2024  proliferation  potential.  NK  cells  derived  from  iPSCs  circumvent  the  challenge  of
                                        difficult genetic modification in NK cells, offering various potential strategies to
            Revised: November 27, 2024  counteract the immune suppression induced by the tumor microenvironment.
            Accepted: December 5, 2024
            Published Online: December 31,   Keywords: Induced pluripotent stem cells; Natural killer cells; Solid cancer; CAR-NK cells;
            2024
                                        Immunotherapy
            Copyright: © 2024 Author(s).
            This is an Open-Access article
            distributed under the terms of the
            Creative Commons Attribution
            License, permitting distribution,   1. Introduction
            and reproduction in any medium,
            provided the original work is   Innate lymphoid cells (ILCs) are classified into three principal groups: Group 1, Group 2,
            properly cited.             and Group 3 ILCs. Natural killer (NK) cells are categorized within Group 1 ILCs, along
                                                1
            Publisher’s Note: AccScience   with ILC1.  Each of these groups has a corresponding counterpart in adaptive immunity
            Publishing remains neutral with   characterized by T helper (Th) cells: Th1 for Group 1, Th2 for Group 2, and Th17 for
            regard to jurisdictional claims in                                                   2
            published maps and institutional   Group 3, reflecting their roles and functions in the immune response.  NK cells, first
            affiliations.               identified in the 1970s, derive their name from their innate ability to kill target cells

            Volume 2 Issue 1 (2025)                         27                               doi: 10.36922/mi.5653
   30   31   32   33   34   35   36   37   38   39   40